|Articles|September 12, 2017

Poll: Were you warned about side effects?

Author(s)Staff

Newsletter

Stay up to date on cancer updates, research and education

Related Content

$The FDA approved Breyanzi for adults with relapsed or refractory marginal zone lymphoma who received at least two prior lines of systemic therapy: © stock.adobe.com.$

FDA Approves Breyanzi in Relapsed/Refractory Marginal Zone Lymphoma

ByAlex Biese

December 4th 2025

Martha Carlson received a diagnosis of metastatic breast cancer in 2015. Read all of Martha's blogs here!

11 Years Living With Stage 4 Cancer Inspires Gratitude and Reflection

ByMartha Carlson

December 4th 2025

An Educational Overview of Newly Diagnosed Stage 1 Myelofibrosis

ByRyan Scott

December 4th 2025

As part of her journey with stage 3 inflammatory breast cancer, Lindsey Gunter experienced chemotherapy side effects so severe that she was unable to walk.

Chemo Side Effects for Breast Cancer Led to Weeks in the Hospital

ByAlex Biese

December 4th 2025

Advice From a Cancer Survivor: Keep Your Appointments!

ByMary Sansone

December 4th 2025

Poll: Were you warned about side effects?

Newsletter

Related Content

FDA Approves Breyanzi in Relapsed/Refractory Marginal Zone Lymphoma

11 Years Living With Stage 4 Cancer Inspires Gratitude and Reflection

An Educational Overview of Newly Diagnosed Stage 1 Myelofibrosis

Chemo Side Effects for Breast Cancer Led to Weeks in the Hospital

Advice From a Cancer Survivor: Keep Your Appointments!

Trending on CURE

Every FDA Oncology Approval From November 2025

Finding Support When People Say Others Have It Worse

Reflecting on My Sister’s Final Days After Years of Unexpected Rebounds

FDA Approves Breyanzi in Relapsed/Refractory Marginal Zone Lymphoma

What Patients Should Know About EGFR Mutated Lung Cancer Treatment